We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+15.78%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$13.5B
AUM Growth
+$1.89B
(+16%)
Cap. Flow
+$532M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
339
New
59
Increased
111
Reduced
94
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$157M |
| 2 |
Johnson & Johnson
JNJ
|
+$155M |
| 3 |
Chegg
CHGG
|
+$87.6M |
| 4 |
Medtronic
MDT
|
+$72.1M |
| 5 |
Humana
HUM
|
+$69.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$133M |
| 2 |
Ciena
CIEN
|
+$99.1M |
| 3 |
Advanced Micro Devices
AMD
|
+$79.2M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$73.2M |
| 5 |
AYX
Alteryx Inc
AYX
|
+$70M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.92% |
| 2 | Healthcare | 20.41% |
| 3 | Financials | 14.55% |
| 4 | Communication Services | 13.91% |
| 5 | Consumer Discretionary | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
101
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $30.1M | 0.22% |
2,568,385
| – | – |
|
102
Merit Medical Systems
MMSI
$5.35B
| $29.9M | 0.22% |
+688,231
| New | +$31.1M |
|
103
S&P Global
SPGI
$131B
| $29.6M | 0.22% |
82,157
-16,782
| -17% | -$5.92M |
|
104
Tandem Diabetes Care
TNDM
$1.38B
| $29M | 0.22% |
255,573
+251,140
| +5,665% | +$26.4M |
|
|
RVNC
105
DELISTED
Revance Therapeutics, Inc.
RVNC
| $28.1M | 0.21% |
1,115,804
-167,409
| -13% | -$4.39M |
|
106
Elevance Health
ELV
$88.4B
| $27.5M | 0.2% |
102,234
-3,876
| -4% | -$1.04M |
|
107
Option Care Health
OPCH
$3.63B
| $27.2M | 0.2% |
2,034,549
+2,011,936
| +8,897% | +$24.5M |
|
108
Alcon
ALC
$34.1B
| $26.6M | 0.2% |
+485,237
| New | +$28.5M |
|
109
Agilent Technologies
A
$42.5B
| $26.1M | 0.19% |
258,963
-54,451
| -17% | -$5.26M |
|
110
Insmed
INSM
$27.6B
| $24.5M | 0.18% |
763,376
+303,026
| +66% | +$8.71M |
|
111
James River Group Holdings
JRVR
$192M
| $24.5M | 0.18% |
550,000
| – | – |
|
|
SGEN
112
DELISTED
Seagen Inc. Common Stock
SGEN
| $24.5M | 0.18% |
125,000
+10,000
| +9% | +$1.67M |
|
113
First American
FAF
$7.43B
| $24.2M | 0.18% |
475,000
| – | – |
|
114
Amgen
AMGN
$236B
| $24.2M | 0.18% |
95,081
+48,000
| +102% | +$11.9M |
|
115
Enovis
ENOV
$1.07B
| $24.1M | 0.18% |
446,998
-16,950
| -4% | -$931K |
|
116
SS&C Technologies
SSNC
$19.6B
| $23.3M | 0.17% |
384,874
-14,594
| -4% | -$873K |
|
117
Accenture
ACN
$114B
| $23.2M | 0.17% |
102,828
+46,503
| +83% | +$10.7M |
|
|
TMHC
118
DELISTED
Taylor Morrison
TMHC
| $22.9M | 0.17% |
932,595
-89,006
| -9% | -$2.1M |
|
119
Intercontinental Exchange
ICE
$90.5B
| $22.5M | 0.17% |
225,282
-8,542
| -4% | -$842K |
|
120
Icon
ICLR
$12.7B
| $22.3M | 0.17% |
116,913
-35,958
| -24% | -$6.61M |
|
121
Dolby
DLB
$5.8B
| $21.9M | 0.16% |
330,724
-12,541
| -4% | -$849K |
|
122
BlackLine
BL
$1.9B
| $21.9M | 0.16% |
244,246
+64,103
| +36% | +$5.38M |
|
|
IMMU
123
DELISTED
Immunomedics Inc
IMMU
| $21.7M | 0.16% |
255,632
-1,447,708
| -85% | -$73.2M |
|
|
PPLI
124
People Inc
PPLI
$2.9B
| $21.4M | 0.16% |
327,447
+232,459
| +245% | +$15.9M |
|
125
RLI Corp
RLI
$5.73B
| $21.4M | 0.16% |
510,000
-25,000
| -5% | -$1.1M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2020 Portfolio in Review
As of Q3 2020, Polar Capital held 339 positions worth $13.5B, up 16% from $11.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Polar Capital deployed $532M of net new capital in Q3 2020, opening 59 new positions and adding to 111 existing holdings. Its largest new stake was Chegg: 1,189,909 shares worth $85M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $133M trimmed.
- Polar Capital's largest Q3 2020 buy was Chegg: 1,189,909 shares worth $85M.
- Polar Capital added most to Meta Platforms (Facebook) in Q3 2020, an estimated $157M increase.
- Polar Capital's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $133M.
- Polar Capital fully exited Ciena in Q3 2020, selling an estimated $99.1M.
- Polar Capital's ten largest holdings make up 32% of its $13.5B portfolio in Q3 2020.
- Polar Capital opened 59 new positions and closed 41 in Q3 2020.
- Polar Capital's portfolio value rose 16% quarter-over-quarter to $13.5B.
Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.